Brazil Targets US Pharma Patents in Retaliation to 25% Tariff
Brazil is preparing retaliatory tariffs on US pharmaceutical patents and audiovisual royalties ahead of a July 22 duty that threatens up to $11 billion in exports and risks spilling over into European agricultural trade.
Washington will impose a 25% tariff on Brazilian goods on July 22, prompting Brasília to draft counter-measures targeting intellectual property revenues rather than simply matching duties. Finance Minister Fernando Haddad and Vice President Geraldo Alckmin have announced an exporter support package, though specific financial commitments remain undisclosed. Brazilian officials have described Secretary of State Marco Rubio’s tone as "arrogant and gross," framing the US demands as a request to "capitulate."
The proposed retaliation zeroes in on areas where American firms extract significant value from the Brazilian market: audiovisual royalties and pharmaceutical patents. This tactic pivots the trade dispute away from traditional manufacturing and into the realm of services and intellectual property. For investors, it signals that Brasília is willing to disrupt the revenue streams of major US pharmaceutical and media companies if the tariffs remain.
The direct export damage falls heavily on specific industries, with footwear facing a projected 7.1% hit, followed by wood products, non-metallic minerals and machinery. The American Chamber of Commerce estimates $11 billion in affected exports, notably higher than the Brazilian government's $7.4 billion figure. Crucially, exporters fear a knock-on suspension of Brazilian meat shipments to the European Union, a development that would send shockwaves through global agricultural commodities.
Brasília is also challenging the legal premise of the tariffs. The government has filed a formal defense in the US Section 301 investigation, explicitly pushing back on claims that Brazil's instant-payment system, Pix, harms American credit-card firms—a rejection endorsed by central-bank president Gabriel Galípolo and the bank lobby ABBC. The Brazilian Supreme Court has adopted a hardline stance, with Justice Edson Fachin stating it "will not yield to external pressure" as Alexandre de Moraes prepares to assume the court's presidency.
The timeline for resolution is complicated by Brazil’s presidential campaign and the threat of further escalation. Brasília is bracing for an additional 12.5% tariff on top of the initial 25%. While the opposition might typically exploit a trade dispute, a PoderData/Aya poll indicates 42% of voters believe Trump’s backing hurts a candidate. With Lula leading Flávio Bolsonaro 40% to 34% in the first round, the political calculus suggests neither side has an incentive to fold, leaving markets facing prolonged uncertainty.
